A detailed history of Simplex Trading, LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Simplex Trading, LLC holds 33,841 shares of OCUL stock, worth $231,472. This represents 0.01% of its overall portfolio holdings.

Number of Shares
33,841
Previous 59,115 42.75%
Holding current value
$231,472
Previous $263,000 16.73%
% of portfolio
0.01%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$3.85 - $10.93 $97,304 - $276,244
-25,274 Reduced 42.75%
33,841 $307,000
Q4 2023

Feb 02, 2024

BUY
$2.08 - $4.52 $122,959 - $267,199
59,115 New
59,115 $263,000
Q2 2023

Aug 04, 2023

SELL
$4.6 - $7.64 $5,556 - $9,229
-1,208 Reduced 0.84%
142,822 $736,000
Q1 2023

Apr 27, 2023

BUY
$2.79 - $6.27 $341,917 - $768,394
122,551 Added 570.56%
144,030 $759,000
Q4 2022

Feb 02, 2023

SELL
$2.61 - $4.41 $78,054 - $131,885
-29,906 Reduced 58.2%
21,479 $60,000
Q3 2022

Nov 04, 2022

BUY
$4.09 - $6.5 $123,141 - $195,702
30,108 Added 141.5%
51,385 $213,000
Q2 2022

Aug 03, 2022

BUY
$3.01 - $5.22 $49,568 - $85,962
16,468 Added 342.44%
21,277 $85,000
Q1 2022

May 02, 2022

SELL
$4.83 - $7.35 $65,147 - $99,136
-13,488 Reduced 73.72%
4,809 $23,000
Q4 2021

Feb 23, 2022

SELL
$6.16 - $12.07 $78,287 - $153,397
-12,709 Reduced 40.99%
18,297 $127,000
Q3 2021

Oct 28, 2021

BUY
$9.7 - $14.34 $26,238 - $38,789
2,705 Added 9.56%
31,006 $444,000
Q2 2021

Aug 12, 2021

SELL
$13.43 - $19.16 $74,523 - $106,318
-5,549 Reduced 16.39%
28,301 $401,000
Q1 2021

Apr 26, 2021

SELL
$15.82 - $22.11 $98,764 - $138,032
-6,243 Reduced 15.57%
33,850 $0
Q4 2020

Feb 02, 2021

BUY
$7.91 - $22.95 $281,390 - $816,423
35,574 Added 787.21%
40,093 $829,000
Q3 2020

Oct 14, 2020

SELL
$7.36 - $9.87 $209,237 - $280,594
-28,429 Reduced 86.28%
4,519 $34,000
Q2 2020

Jul 13, 2020

BUY
$4.67 - $8.95 $114,513 - $219,462
24,521 Added 290.98%
32,948 $274,000
Q1 2020

Apr 29, 2020

SELL
$3.95 - $7.4 $138,684 - $259,814
-35,110 Reduced 80.64%
8,427 $41,000
Q4 2019

Feb 05, 2020

BUY
$2.57 - $4.73 $59,603 - $109,698
23,192 Added 113.99%
43,537 $171,000
Q3 2019

Oct 15, 2019

SELL
$3.04 - $5.32 $213,325 - $373,320
-70,173 Reduced 77.52%
20,345 $61,000
Q2 2019

Jul 26, 2019

BUY
$2.46 - $4.52 $222,674 - $409,141
90,518 New
90,518 $398,000
Q1 2019

Apr 18, 2019

SELL
$3.51 - $4.77 $26,300 - $35,741
-7,493 Closed
0 $0
Q4 2018

Jan 16, 2019

SELL
$3.87 - $7.11 $50,151 - $92,138
-12,959 Reduced 63.36%
7,493 $29,000
Q3 2018

Oct 23, 2018

BUY
$5.42 - $6.99 $110,849 - $142,959
20,452 New
20,452 $140,000
Q4 2017

Jan 10, 2018

SELL
$3.73 - $6.37 $7,187 - $12,274
-1,927 Closed
0 $0
Q3 2017

Oct 25, 2017

BUY
$5.28 - $6.88 $10,174 - $13,257
1,927
1,927 $11,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $526M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.